GADD34 Blocking Peptide for STJ501133 peptide (STJ504123)
SPECIFICATIONS
ImmunogenSynthetic peptide corresponding to internal sequence of amino acids 380-400 of Human GADD34, covalently modified and coupled to a carrier protein. Sequence: PATGVFLKSWVYQPGEDTEEE
General Information
| Short Description | GADD34 Blocking Peptide for STJ501133 is synthetically produced from the 380-400 sequence and is suitable for use in western blot applications. |
| Applications | Immunodepletion/Immunocompetition |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Formulation | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
Target Information
| Immunogen | Synthetic peptide corresponding to internal sequence of amino acids 380-400 of Human GADD34, covalently modified and coupled to a carrier protein. Sequence: PATGVFLKSWVYQPGEDTEEE |
| Immunogen Region | 380-400 |
| Specificity | This blocking peptide is recommended for use in combination with GADD34 antibody, STJ501133 |
Additional Info
| Background | Recruits serine/threonine-protein phosphatase PP1 to dephosphorylate translation initation factor eIF2A/EIF2S1. This reverses shut-off of protein synthesis initiated by stress-inducible kinases and facilitating recovery of cells from stress. |
Information sourced from Uniprot.org